Search Results - "Narod, Steven"

Refine Results
  1. 1

    Which Genes for Hereditary Breast Cancer? by Narod, Steven A

    Published in The New England journal of medicine (04-02-2021)
    “…Results of two large case–control studies that analyzed the associations between a number of putative cancer susceptibility genes and breast cancer risk are…”
    Get full text
    Journal Article
  2. 2

    The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer by Sopik, Victoria, Narod, Steven A.

    Published in Breast cancer research and treatment (01-08-2018)
    “…Background In patients with breast cancer, increasing tumour size at diagnosis is associated with an increased likelihood of axillary lymph node involvement…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Breast cancer in young women by Narod, Steven A.

    Published in Nature reviews. Clinical oncology (01-08-2012)
    “…Breast cancers in young women are typically aggressive and so young age can correlate with a poorer outcome. In this Review article, Steven Narod discusses the…”
    Get full text
    Journal Article
  5. 5

    Personalised medicine and population health: breast and ovarian cancer by Narod, Steven A.

    Published in Human genetics (01-10-2018)
    “…It has been suggested that a personalised approach to cancer prevention and screening might lead to a new paradigm for cancer control. Various aspects include…”
    Get full text
    Journal Article
  6. 6

    Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ by Sopik, Victoria, Sun, Ping, Narod, Steven A.

    Published in Breast cancer research and treatment (01-02-2018)
    “…Background Ductal carcinoma in situ (DCIS) is a neoplastic proliferation of epithelial cells which is confined within the basement membrane of the mammary…”
    Get full text
    Journal Article
  7. 7

    Differences in Breast Cancer Stage at Diagnosis and Cancer-Specific Survival by Race and Ethnicity in the United States by Iqbal, Javaid, Ginsburg, Ophira, Rochon, Paula A, Sun, Ping, Narod, Steven A

    “…IMPORTANCE: Women with early-stage breast cancers are expected to have excellent survival rates. It is important to identify factors that predict diagnosis of…”
    Get full text
    Journal Article
  8. 8

    CA125 and Ovarian Cancer: A Comprehensive Review by Charkhchi, Parsa, Cybulski, Cezary, Gronwald, Jacek, Wong, Fabian Oliver, Narod, Steven A, Akbari, Mohammad R

    Published in Cancers (11-12-2020)
    “…Ovarian cancer is the second most lethal gynecological malignancy. The tumour biomarker CA125 has been used as the primary ovarian cancer marker for the past…”
    Get full text
    Journal Article
  9. 9

    Is invasion a necessary step for metastases in breast cancer? by Narod, Steven A., Sopik, Victoria

    Published in Breast cancer research and treatment (01-05-2018)
    “…Purpose To review the empirical evidence to support the conventional (sequential) model of breast cancer progression, which is based on the paradigm that…”
    Get full text
    Journal Article
  10. 10

    Adjuvant olaparib — should all patients with breast cancer have genetic testing? by Narod, Steven A.

    Published in Nature reviews. Clinical oncology (01-10-2021)
    “…The paradigm of precision medicine implies that breast cancer treatment should be tailored based on inherent risk of recurrence and/or individual sensitivity…”
    Get full text
    Journal Article
  11. 11

    Hormone replacement therapy and the risk of breast cancer by Narod, Steven A

    Published in Nature reviews. Clinical oncology (01-11-2011)
    “…Hormone replacement therapy (HRT) has been linked by several reports to an increased risk of breast cancer. The precipitous decrease in breast cancer incidence…”
    Get full text
    Journal Article
  12. 12

    Prophylactic salpingectomy for the prevention of ovarian cancer: Who should we target? by Kotsopoulos, Joanne, Narod, Steven A.

    Published in International journal of cancer (01-09-2020)
    “…Ovarian cancer is the most fatal gynecologic malignancy (50% 5‐year survival) due to a typically advanced stage at diagnosis and a high rate of recurrence…”
    Get full text
    Journal Article
  13. 13

    BRCA mutations in the management of breast cancer: the state of the art by Narod, Steven A

    Published in Nature reviews. Clinical oncology (01-12-2010)
    “…Genetic testing for breast cancer susceptibility is widely available in North America and in Europe. The optimum treatment of women with breast (or ovarian)…”
    Get full text
    Journal Article
  14. 14

    The risk of contralateral breast cancer: a SEER-based analysis by Giannakeas, Vasily, Lim, David W., Narod, Steven A.

    Published in British journal of cancer (17-08-2021)
    “…Background We sought to estimate the annual risk and 25-year cumulative risk of contralateral breast cancer among women with stage 0–III unilateral breast…”
    Get full text
    Journal Article
  15. 15

    Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ by Narod, Steven A, Iqbal, Javaid, Giannakeas, Vasily, Sopik, Victoria, Sun, Ping

    Published in JAMA oncology (01-10-2015)
    “…Women with ductal carcinoma in situ (DCIS), or stage 0 breast cancer, often experience a second primary breast cancer (DCIS or invasive), and some ultimately…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Low-grade serous ovarian cancer: A review by Kaldawy, Anis, Segev, Yakir, Lavie, Ofer, Auslender, Ron, Sopik, Victoria, Narod, Steven A

    Published in Gynecologic oncology (01-11-2016)
    “…Abstract Epithelial ovarian cancers can be divided into the more common, aggressive type II cancers and the less common, slow-growing type I cancers. Under…”
    Get full text
    Journal Article
  18. 18

    Bilateral breast cancers by Narod, Steven A.

    Published in Nature reviews. Clinical oncology (01-03-2014)
    “…Key Points On average, the annual risk of contralateral breast cancer following a diagnosis of breast cancer is 0.5%, but this risk varies between individuals…”
    Get full text
    Journal Article
  19. 19
  20. 20

    The expected benefit of preventive mastectomy on breast cancer incidence and mortality in BRCA mutation carriers, by age at mastectomy by Giannakeas, Vasily, Narod, Steven A.

    “…Purpose Preventive breast surgery is offered to unaffected BRCA mutation carriers to prevent breast cancer incidence and mortality. The clinical benefit of…”
    Get full text
    Journal Article